U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Wed Apr 02 20:28:58 GMT 2025
Edited
by admin
on Wed Apr 02 20:28:58 GMT 2025
Protein Type BISPECIFIC ANTIBODY
Protein Sub Type BISPECIFIC T CELL ENGAGER|IGG1|KAPPA
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
8YNA3QG3DS
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Nesfrotamig
INN  
Official Name English
ABL-105
Preferred Name English
YH32367
Code English
H-gamma1 heavy chain anti-ERBB2 fused to a scFvlh anti-TNFRSF9 (1-719) [H-gamma1 heavy chain anti-ERBB2 humanized (1-450) [VH (Homo sapiens IGHV3-66*01 (81.6%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.13] (26-33.51-58.97-109)) (1-120)-Homo sapiens IGHG1*0
Common Name English
Immunoglobulin G1, bispecific, anti-(human/Macaca fascicularis epidermal growth factor receptor HER2) (human-Mus musculus monoclonal YH32367 ?1-chain) fusion protein with peptide linker ((GS)9) fusion protein with immunoglobulin anti-(human/Macaca fascic
Common Name English
HER2/4-1BB bispecific antibody, YH32367
Common Name English
nesfrotamig [INN]
Common Name English
ABL105
Code English
YH-32367
Code English
immunoglobulin (H-gamma1-scFvlh_L-kappa) dimer, anti-[Homo sapiens ERBB2 (receptor tyrosine-protein kinase erbB-2, epidermal growth factor receptor 2, EGFR2, HER2, HER-2, p185c-erbB2, NEU, CD340)] and anti-[Homo sapiens TNFRSF9 (TNF receptor superfamily
Common Name English
Code System Code Type Description
INN
13381
Created by admin on Wed Apr 02 20:28:58 GMT 2025 , Edited by admin on Wed Apr 02 20:28:58 GMT 2025
PRIMARY
CAS
2966936-23-0
Created by admin on Wed Apr 02 20:28:58 GMT 2025 , Edited by admin on Wed Apr 02 20:28:58 GMT 2025
PRIMARY
NCI_THESAURUS
C192011
Created by admin on Wed Apr 02 20:28:58 GMT 2025 , Edited by admin on Wed Apr 02 20:28:58 GMT 2025
PRIMARY
FDA UNII
8YNA3QG3DS
Created by admin on Wed Apr 02 20:28:58 GMT 2025 , Edited by admin on Wed Apr 02 20:28:58 GMT 2025
PRIMARY
From To
4_23 4_88
4_134 4_194
3_134 3_194
3_23 3_88
2_642 2_694
2_571 2_620
2_490 2_557
2_370 2_428
2_264 2_324
2_223 4_214
2_147 2_203
2_22 2_96
1_642 1_694
1_571 1_620
1_490 1_557
1_370 1_428
1_264 1_324
1_232 2_232
1_229 2_229
1_223 3_214
1_147 1_203
1_22 1_96
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_300
N 2_300
Related Record Type Details
TARGET -> ACTIVATOR
Activates T-cells targeted to Her-2
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL